Speed Profile, Celgene Corporation (CELG)
Company Name: Celgene Corporation
Logo:
Speed Profile: Celegene Corp is a biopharmaceutical company that develops therapies to treat cancer and immune-inflammatory related diseases. Several drugs currently available include Revlimid, Thalomid, and Alkeran.
Celgene stock went public through its IPO on 7/28/1987.
Stock Symbol: CELG
Index Participation: S&P 500 (YES), NASDAQ Composite (NO), Dow Jones Industrials (NO)
Sector, Industry: Healthcare, Biotechnology











